Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

v2.4.0.6
Consolidated Statements of Shareholders' Equity (USD $)
In Thousands, except Share data
Total
Series A Preferred Stock
Series C Preferred Stock
Common Stock
Common Stock
Series A Preferred Stock
Common Stock
Series D Preferred Stock
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series A Preferred Stock
Additional Paid-in Capital
Series D Preferred Stock
Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Series A Preferred Stock
Pharmacos Exakta
Common Stock
Pharmacos Exakta
Additional Paid-in Capital
Claros
Claros
Common Stock
Claros
Treasury Stock
Claros
Additional Paid-in Capital
FineTech
FineTech
Common Stock
FineTech
Additional Paid-in Capital
Beginning balance at Dec. 31, 2008 $ 359 $ 10 $ 0 $ 1,991     $ (24) $ 307,498     $ 0 $ (309,116)                    
Beginning balance, shares at Dec. 31, 2008   953,756 0 199,020,379     (18,000)                              
Equity-based compensation expense 4,498             4,498                            
Exercise of common stock options 694     30       664                            
Exercise of common stock options, shares       2,984,945                                    
Exercise of common warrants 24     7       17                            
Exercise of common warrants, shares       706,164                                    
Issuance of common stock in private placement to related party 20,000     200       19,800                            
Issuance of common stock in private placement to related party, shares       20,000,000                                    
Issuance of common stock in private placement, including related parties 30,990     310       30,680                            
Issuance of common stock in private placement, including related parties, share       31,000,000                                    
Relative fair value of warrants issued In connection with issuance of Series D preferred stock 3,872                 3,872                        
Series A preferred stock dividend   1             (1)                          
Series A preferred stock dividend, shares   93,242                                        
Conversion of Series A preferred stock (1) (1)                                        
Conversion of Series A preferred stock, shares   (21,064)     21,064                                  
Restricted stock grant       30,000                                    
Purchase of shares (37)           (37)                              
Purchase of shares, shares             (27,154)                              
Net loss (30,113)                     (30,113)                    
Cumulative translation adjustment net 1,313                   1,313                      
Ending balance at Dec. 31, 2009 31,599 10 0 2,538     (61) 367,028     1,313 (339,229)                    
Ending balance, shares at Dec. 31, 2009   1,025,934 0 253,762,552     (45,154)                              
Equity-based compensation expense 6,922             6,922                            
Exercise of common stock options 74     2       72                            
Exercise of common stock options, shares       150,231                                    
Series A preferred stock dividend (224)                       (224)                  
Conversion of Series A preferred stock   (1)     1                                  
Conversion of Series A preferred stock, shares   (128,495)     128,495                                  
Net loss (18,926)                     (18,926)                    
Cumulative translation adjustment net 1,608                   1,608                      
Issuance of common stock in Connection with acquisition 1,999                         13 1,986              
Issuance of common stock in Connection with acquisition, shares                           1,371,428                
Ending balance at Dec. 31, 2010 23,052 9 0 2,554     (61) 376,008     2,921 (358,379)                    
Ending balance, shares at Dec. 31, 2010   897,439 0 255,412,706     (45,154)                              
Equity-based compensation expense 7,155             7,155                            
Exercise of common stock options 984     4       980                            
Exercise of common stock options, shares       422,500                                    
Exercise of common warrants 260     29       231                            
Exercise of common warrants, shares       2,925,894                                    
Series A preferred stock dividend (4,704) (60)               (4,704)     (60)                  
Conversion of Series A preferred stock 1,742 (3)     3 10       1,732                        
Conversion of Series A preferred stock, shares   (294,680)     294,680 940,141                                
Purchase of shares (7,832)           (7,832)                              
Purchase of shares, shares             (2,398,740)                              
Net loss (1,283)                     (1,283)                    
Other comprehensive loss (2,014)                   (2,014)                      
Redemption of Series A preferred stock (1,507) (6)             (1,501)                          
Redemption of Series A preferred stock, shares   (602,759)                                        
Issuance of common stock at $3.75 per share 104,828     294       104,534                            
Issuance of common stock at $3.75 per share, shares       29,397,029                                    
Issuance of common stock in Connection with acquisition                               22,452 45 (199) 22,606 17,717 36 17,681
Issuance of common stock in Connection with acquisition, shares                                 4,494,380 (44,583)     3,615,703  
Exakta-OPKO purchase price adjustment 92             92                            
Ending balance at Dec. 31, 2011 $ 160,882 $ 0 $ 0 $ 2,975     $ (8,092) $ 524,814     $ 907 $ (359,722)                    
Ending balance, shares at Dec. 31, 2011   0 0 297,503,033     (2,488,477)